EQUILLIUM, INC. Proceeds from Stock Options Exercised
EQUILLIUM, INC. (EQ) reported Proceeds from Stock Options Exercised of $583.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-13
- EQUILLIUM, INC. proceeds from stock options exercised for the quarter ending 2026-06-30 was $135.00K.
- EQUILLIUM, INC. proceeds from stock options exercised for the quarter ending 2026-03-31 was $448.00K, a 1078.95% increase year-over-year.
- EQUILLIUM, INC. proceeds from stock options exercised for the quarter ending 2025-12-31 was $604.00K.
- EQUILLIUM, INC. proceeds from stock options exercised for the quarter ending 2025-09-30 was $1.19M.
- EQUILLIUM, INC. proceeds from stock options exercised for fiscal 2025 was $1.84M, a 45800.00% increase from fiscal 2024.
- EQUILLIUM, INC. proceeds from stock options exercised for fiscal 2024 was $4.00K.
- EQUILLIUM, INC. proceeds from stock options exercised for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- EQUILLIUM, INC. proceeds from stock options exercised for fiscal 2021 was $891.00K, a 12628.57% increase from fiscal 2020.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $583.00K 10-Q · filed 2026-08-13 | $1.19M derived: sum of 3 quarters · filed 2026-08-13 | $2.38M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $448.00K 10-Q · filed 2026-05-13 | $1.05M derived: sum of 2 quarters · filed 2026-05-13 | $2.25M derived: sum of 3 quarters · filed 2026-05-13 | $2.25M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.80M derived: sum of 2 quarters · filed 2026-03-25 | $1.80M derived: sum of 3 quarters · filed 2026-08-13 | $1.84M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.19M derived: sum of 2 quarters · filed 2026-08-13 | $1.23M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $38.00K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | $4.00K 10-K · filed 2026-03-25 | ||||
| 2022-12-31 | $0.00 10-K · filed 2023-03-23 | ||||
| 2021-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $265.00K derived: sum of 2 quarters · filed 2023-03-23 | $887.00K derived: sum of 3 quarters · filed 2023-03-23 | $891.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $796.00K derived: sum of 2 quarters · filed 2022-11-14 | $800.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $622.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $626.00K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $7.00K 10-K · filed 2022-03-23 | ||||
| 2019-12-31 | $69.00K 10-K · filed 2021-03-24 | ||||
| 2018-12-31 | $291.00K 10-K · filed 2020-03-26 | $291.09K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |